CAT-09-ADC

N/A

Report date: 2025/01/26 19:11:55

Base Information

Drug NameCAT-09-ADC

Drug Alias NameMuc1-targeting antibody drug conjugate (Catalent)CAT-09-ADC

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionMucin-1 modulators

TargetsMucin-1

Therapy Area/IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCatalent Inc

China Registration ClassN/A

Active CompaniesCatalent Inc

Inactive CompaniesN/A

Active IndicationsLung NeoplasmsOvarian NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

ATC CodeN/A